Wells Fargo Maintains Overweight on Cardinal Health, Lowers Price Target to $245

Benzinga Newsdesk www.benzinga.com Negative 89.5%

Neg 89.5% Neu 0% Pos 0%

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and lowers the price target from $256 to $245.